s6y
Company name or ticker
Search
Sumitovant Biopharma Ltd.
4
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
Filed
Thursday, May 21, 2020
Period
May 19, 2020
Accession number
0000899243-20-013825
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header